These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Clinical pharmacokinetics of furosemide during continuous ambulatory peritoneal dialysis]. Boutron H; Singlas E; Brocard JF; Charpentier B; Fries D Therapie; 1985; 40(3):155-9. PubMed ID: 4012661 [No Abstract] [Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic effects of furosemide in patients with impaired renal function. Traeger A; Stein G; Sperschneider H; Keil E Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):481-6. PubMed ID: 6500766 [TBL] [Abstract][Full Text] [Related]
6. [Significance of sodium excretion fraction determination with a view to heavy doses of furosemide in patients with chronic renal failure (author's transl)]. Erben J; Schück O; Zahradník J Cas Lek Cesk; 1981 Jun; 120(23):695-8. PubMed ID: 7249034 [No Abstract] [Full Text] [Related]
7. [Technic of maintained diuresis with sodium load and furosemide: treatment of severe episodes of chronic renal insufficiency]. Petrover M; Prieur P Nouv Presse Med; 1973 Oct; 2(38):2525-30. PubMed ID: 4763457 [No Abstract] [Full Text] [Related]
8. [Use of high-dose furosemide in patients undergoing regular hemodialysis]. Ragni R; Stratta P; Dogliani M; Segoloni G; Piccoli G Minerva Med; 1972 Oct; 63(70):3797-805. PubMed ID: 5079121 [No Abstract] [Full Text] [Related]
9. Metabolic clearance of furosemide in the rat. Wallin JD; Ryals P; Kaplowitz N J Pharmacol Exp Ther; 1977 Jan; 200(1):52-7. PubMed ID: 833762 [TBL] [Abstract][Full Text] [Related]
10. Determinants of furosemide delivery to its site of action. Sjöström PA; Kron BG; Odlind BG Clin Nephrol; 1995 Jan; 43 Suppl 1():S38-41. PubMed ID: 7781204 [TBL] [Abstract][Full Text] [Related]
12. High-dose furosemide (Lasix) in renal insufficiency. Seedat YK S Afr Med J; 1972 Sep; 46(38):1371-4. PubMed ID: 4638226 [No Abstract] [Full Text] [Related]
13. [Optimal dosage of furosemide in patients treated with repeated dialysis]. Jacobs C; Singlas E; Lockmane H; Tillement JP; Simon P; Legrain M J Urol Nephrol (Paris); 1975 Sep; 81(9):697-702. PubMed ID: 1214314 [No Abstract] [Full Text] [Related]
14. [Comparison of various pharmacological and conventional methods of increasing the effectiveness of peritoneal dialysis. I. Intraperitoneal or intravenous use of furosemide during intermittent peritoneal dialysis]. Grzegorzewska A Przegl Lek; 1988; 45(4):365-73. PubMed ID: 3212200 [No Abstract] [Full Text] [Related]
15. [Effect of sodium nitroprusside, furosemide and dopamine on the efficiency of peritoneal dialysis]. Panasiuk E Pol Arch Med Wewn; 1985; 74(5-6):316-26. PubMed ID: 3880302 [No Abstract] [Full Text] [Related]
16. Use of frusemide in the oliguria of acute and chronic renal failure. Sullivan JF; Kreisberger C; Mittal AK Postgrad Med J; 1971 Apr; 47():Suppl:26-8. PubMed ID: 5579766 [No Abstract] [Full Text] [Related]
17. [Conservative therapy in chronic renal failure]. Ratner MIa Klin Med (Mosk); 1992; 70(5-6):75-7. PubMed ID: 1434412 [No Abstract] [Full Text] [Related]